Neurogene Inc. (NGNE)
NASDAQ: NGNE · Real-Time Price · USD
35.34
+1.46 (4.31%)
At close: Jul 2, 2026, 4:00 PM EDT
34.78
-0.56 (-1.58%)
After-hours: Jul 2, 2026, 7:50 PM EDT
Neurogene Employees
Neurogene had 131 employees as of December 31, 2025. The number of employees increased by 24 or 22.43% compared to the previous year.
Employees
131
Change (1Y)
24
Growth (1Y)
22.43%
Revenue / Employee
n/a
Profits / Employee
-$752,962
Market Cap
558.44M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 131 | 24 | 22.43% |
| Dec 31, 2024 | 107 | 16 | 17.58% |
| Dec 31, 2023 | 91 | 9 | 10.98% |
| Jun 30, 2023 | 82 | - | - |
| Dec 31, 2022 | 82 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| MiMedx Group | 808 |
| Arvinas | 246 |
| Cabaletta Bio | 158 |
| Kyverna Therapeutics | 129 |
| Editas Medicine | 87 |
| Assembly Biosciences | 73 |
| Crescent Biopharma | 55 |
| Contineum Therapeutics | 51 |
NGNE News
- 1 day ago - Neurogene prices 3.5M shares at $30.00 in public offering - TheFly
- 1 day ago - Neurogene Inc. Announces Pricing of $125 Million Public Offering - Business Wire
- 2 days ago - Neurogene 75M Spot Secondary; re-offered at $30.00 - TheFly
- 2 days ago - Neurogene announces common stock offering, no amount given - TheFly
- 2 days ago - Neurogene Inc. Announces Proposed Public Offering - Business Wire
- 3 days ago - Neurogene Transcript: Study result - Transcripts
- 3 days ago - Neurogene Press release: Study result - Filings
- 3 days ago - Neurogene Slides: Study result - Filings